We are inviting you to take part in a clinical study.
Those who take part in a study will include various visits to a study center near the participant’s home.
There is no cost to participate in the study. All study-related care, including the study drug will be provided. Those who take part in the study may receive reimbursement.
You may be eligible to participate in a Relapsing Multiple Sclerosis Study if you:
- Are between 18 and 55 years old
- Are diagnosed with RMS
- Have a recent history of RMS, with at least 2 relapses in the last 2 years or 1 relapse in the last year
Sign Up
What happens if I sign up? We will match you to a study center location in your area that needs volunteers with Relapsing Multiple Sclerosis or notify you when one becomes available. The study team will then contact you and you may have the opportunity to participate if qualified.
If you think you might like to participate in a Relapsing Multiple Sclerosis Studies or would like more information, please enter your information below so we can see if you may qualify and can contact you about the studies. Keep in mind that participation is entirely voluntary. If you do decide to take part in a study, you may change your mind about participating at any time.
About Relapsing Multiple Sclerosis
Relapsing Multiple Sclerosis (RMS) is the most prevalent form of multiple sclerosis, affecting approximately 85% of individuals diagnosed with MS. Symptoms can vary widely but often include fatigue, weakness, sensory disturbances, visual problems, difficulties with balance and coordination, cognitive impairment, and bladder or bowel dysfunction.1
While RMS is a chronic condition with no cure, ongoing research and clinical trials continue to advance our understanding and improve patient outcomes.
Frequently Asked Questions
What is a research study?
A research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug – these may include how well an investigational study drug works for a certain condition. All medications must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are research studies important?
A research study is the process by which new and innovative medications, interventions and treatments are approved and brought to market, so people can live happier and healthier lives. Even over-the-counter medications, such as NSAIDs, you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
What else do I need to consider?
The research team will be able to explain more about what the Relapsing Multiple Sclerosis Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study center?
We match you to a study center within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decided you no longer want your information stored, you can opt out and we will delete your details.
About the Relapsing Multiple Sclerosis Studies
The Relapsing Multiple Sclerosis Studies are enrolling adult participants diagnosed with Relapsing Multiple Sclerosis. The study may involve regular visits to a study center in your area.
Participants will receive all study-related care from a dedicated medical team at no cost to you or your insurance.
Who can take part in a Relapsing Multiple Sclerosis Study?
You may be eligible to participate in a Relapsing Multiple Sclerosis study if you:
- Are between 18 and 55 years old
- Are diagnosed with RMS
- Have a recent history of RMS, with at least 2 relapses in the last 2 years or 1 relapse in the last year
